MX9306222A - Composiciones farmaceuticas de 2-oxindol-1-carboxamidas 3-sustituidas. - Google Patents

Composiciones farmaceuticas de 2-oxindol-1-carboxamidas 3-sustituidas.

Info

Publication number
MX9306222A
MX9306222A MX9306222A MX9306222A MX9306222A MX 9306222 A MX9306222 A MX 9306222A MX 9306222 A MX9306222 A MX 9306222A MX 9306222 A MX9306222 A MX 9306222A MX 9306222 A MX9306222 A MX 9306222A
Authority
MX
Mexico
Prior art keywords
oxindol
carboxamides
substituted
pharmaceutical compositions
formula
Prior art date
Application number
MX9306222A
Other languages
English (en)
Spanish (es)
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9306222A publication Critical patent/MX9306222A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
MX9306222A 1992-10-07 1993-10-06 Composiciones farmaceuticas de 2-oxindol-1-carboxamidas 3-sustituidas. MX9306222A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (1)

Publication Number Publication Date
MX9306222A true MX9306222A (es) 1994-04-29

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306222A MX9306222A (es) 1992-10-07 1993-10-06 Composiciones farmaceuticas de 2-oxindol-1-carboxamidas 3-sustituidas.

Country Status (21)

Country Link
EP (1) EP0662831A1 (ru)
JP (1) JP2721042B2 (ru)
KR (1) KR950703338A (ru)
CN (1) CN1089138A (ru)
AU (1) AU676200B2 (ru)
BR (1) BR9307182A (ru)
CA (1) CA2146448A1 (ru)
CZ (1) CZ282702B6 (ru)
EG (1) EG20289A (ru)
FI (1) FI934387A (ru)
HU (1) HUT68533A (ru)
IL (1) IL107122A (ru)
MX (1) MX9306222A (ru)
MY (1) MY109680A (ru)
NO (1) NO951350L (ru)
NZ (1) NZ256164A (ru)
PL (1) PL174170B1 (ru)
RU (1) RU2119353C1 (ru)
TW (1) TW438798B (ru)
WO (1) WO1994007488A1 (ru)
ZA (1) ZA937405B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
UA42739C2 (ru) * 1995-04-24 2001-11-15 Пфайзер Інк. Способ ингибирования фотораспада фармацевтически активных соединений, таблетка и капсула, их содержащие
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
JP5869764B2 (ja) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 カプセル充填用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
DE69216642T2 (de) * 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit

Also Published As

Publication number Publication date
NO951350L (no) 1995-06-06
FI934387A (fi) 1994-04-08
EP0662831A1 (en) 1995-07-19
EG20289A (en) 1998-07-30
TW438798B (en) 2001-06-07
PL174170B1 (pl) 1998-06-30
AU4839293A (en) 1994-04-26
HUT68533A (en) 1995-04-27
CZ282702B6 (cs) 1997-09-17
WO1994007488A1 (en) 1994-04-14
KR950703338A (ko) 1995-09-20
HU9302821D0 (en) 1993-12-28
NZ256164A (en) 1997-03-24
CA2146448A1 (en) 1994-04-14
PL308307A1 (en) 1995-07-24
FI934387A0 (fi) 1993-10-06
ZA937405B (en) 1995-04-06
CZ87895A3 (en) 1995-10-18
BR9307182A (pt) 1999-03-30
NO951350D0 (no) 1995-04-06
IL107122A0 (en) 1993-12-28
IL107122A (en) 1998-08-16
CN1089138A (zh) 1994-07-13
MY109680A (en) 1997-04-30
AU676200B2 (en) 1997-03-06
RU2119353C1 (ru) 1998-09-27
JPH07507809A (ja) 1995-08-31
JP2721042B2 (ja) 1998-03-04

Similar Documents

Publication Publication Date Title
HUP9900925A2 (hu) Napfényt szűrő készítmények
ES2179823T3 (es) Inmunosupresor macrolido.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
DE69426629D1 (de) Therapeutische verbindung - fettsäurekonjugate
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
PA8436201A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2100187T3 (es) Derivados de carboestirilos y composiciones farmaceuticas que los contienen.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1280604B1 (it) Gruppo di potenza per l'alimentazione di attuatori idraulici
MX9203357A (es) Derivados de pirido(2,3-d)pirimidina y composiciones farmaceuticas que los contienen.
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
FI932079A (fi) Foerfarande foer framstaellning av N-alkylpolyhydroxiaminer i amin- och amin/vattenloesningar och fettsyraamider daerav
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
CO4930276A1 (es) Nuevos derivados de aminofosfohato y proceso de prepara cion
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9302116A (es) Compuestos azabiciclo.
ES2081446T3 (es) Derivados de pirimidinadiona-2,4 y los medicamentos que los contienen.
MX9306222A (es) Composiciones farmaceuticas de 2-oxindol-1-carboxamidas 3-sustituidas.
NO163331C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer.
ES2143833T3 (es) Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen.
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.